Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Kenneth Jahan"'
Autor:
Kenneth Olivier, Ribhu Nayar, Sonal Jangalwe, Mollie Jurewicz, Antoine Boudot, Robert Prenovitz, Elizabeth Olesin, Daniel Pollacksmith, Qikai Xu, Yifan Wang, Amy Virbasius, Jeffery Li, Holly Whitton, Garrett Dunlap, Alexander Cristofaro, Nancy Nabilsi, Ruan Zhang, Candace Perullo, Sida Liao, Kenneth Jahan, Gavin MacBeath
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/d8b81dd10b4b49dd8f55a003956d8da4
Autor:
Mollie Jurewicz, Elizabeth Hall, Alexandra Luther, Kimberly Cirelli, Vivin Karthik, Kenneth Jahan, Tary Traore, Maytal Bowman, Victor Ospina, Sonal Jangalwe, Shubhangi Kamalia, Sadie Lee, Daniel Pollacksmith, Sida Liao, Amy Virbasius, Kristen Murray, Jillian Oliveira, Lisa Nip, Christina Lam, Livio Dukaj, Danielle Ramsdell, Jin He, Joel Sher, Ribhu Nayar, Qikai Xu, Yifan Wang, Antoine Boudot, Cagan Gurer, Gavin MacBeath
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Ribhu Nayar, Sonal Jangalwe, Mollie Jurewicz, Antoine Boudot, Andrew Basinski, Robert Prenovitz, Elizabeth Olesin, Daniel Pollacksmith, Qikai Xu, Yifan Wang, Amy Virbasius, Jeffery Li, Holly Whitton, Garrett Dunlap, Alexander Cristofaro, Nancy Nabilsi, Ruan Zhang, Candace Perullo, Sida Liao, Kenneth Jahan, Kenneth Olivier, Gavin MacBeath
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Background Approximately 30–40% of AML patients relapse following allogeneic hematopoietic stem cell transplant therapy, leaving them with very few treatment options.1 2 Rare patients that naturally develop an HA-1-specific graft-versus-leukemia T
Autor:
Kenneth Jahan, Steven G. Young, Brent H. Cochran, Emilee Holtzapple, Natasa Miskov-Zivanov, Yahan Zhang
Publikováno v:
Neuro-Oncology. 20:vi45-vi45
Despite a tremendous increase in knowledge about glioblastoma in recent years, it has proven difficult to devise new effective therapies. It is likely that a major reason for the failure of new therapies is due to the molecular heterogeneity of GBM b
Autor:
Jian-Hua Mao, Jia-Li Tan, Yucheng Wang, Zhidong Xu, David M. Jablons, Tong Li, Hannah Roos, Liang You, Kenneth Jahan, Ming-Szu Hung
The Cullin 4A (Cul4A) gene is important in cell survival, development, growth, and cell cycle control and is amplified in breast and hepatocellular cancers. Recently, we reported that Cul4A plays an oncogenic role in the pathogenesis of mesothelioma.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::475c85156935072338efa0fc0fbc78e7
https://europepmc.org/articles/PMC3285554/
https://europepmc.org/articles/PMC3285554/